Formation of DNA modifications by chemical carcinogens. Identification, localization and quantification.
D016604:Aflatoxin B1; D000348:Aflatoxins / Q000378:metabolism; D000818:Animals; D000906:Antibodies; D000911:Antibodies, Monoclonal; D001564:Benzo(a)pyrene / Q000378:metabolism; D001812:Blood-Brain Barrier; D001814:Blood-Testis Barrier; D002273:Carcinogens / Q000378:metabolism*; D003520:Cyclophosphamide / Q000378:metabolism; D004247:DNA / Q000378:metabolism*; D004277:DNA, Single-Stranded / Q000276:immunology; D005038:Ethylnitrosourea / Q000378:metabolism; D005260:Female; D006147:Guanine / Q000378:metabolism; D006651:Histocytochemistry; D006801:Humans; D008099:Liver / Q000378:metabolism; D008297:Male; D009690:Nucleic Acid Conformation / Q000187:drug effects*; D012137:Respiratory System / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D014018:Tissue Distribution
D000348:Aflatoxins; D000906:Antibodies; D000911:Antibodies, Monoclonal; D002273:Carcinogens; D004277:DNA, Single-Stranded; D001564:Benzo(a)pyrene; D006147:Guanine; D003520:Cyclophosphamide; D004247:DNA; D016604:Aflatoxin B1; D005038:Ethylnitrosourea